CRITICAPHARMA

Our goal is to become a leading Specialty Pharmaceutical Company focused on the commercialization of Innovative, Orphan and Added Value Drugs for Greece, Cyprus and Malta... Our strategy is to drive organic growth by leveraging our existing product portfolio, supporting recent and future product launches, acquiring and/or licensing new products, and through further development of existing molecules to better meet the needs of patients... We are keen to introduce new products to our markets. We provide professional and ethical in-market promotion while respecting the highest compliance standards; this includes KOLs visits, local, national and international educational events, and sales and distribution monitoring, customer support and other key functions critical to achieving the commercial success of the new product.

Also known as: CRITICA Pharmaceutical

Primary location: Athens Greece